Results

Our proven
track record.

  • We represented a University in its spinout of a biopharmaceutical company and subsequent $32 million Series A financing, including an agreement granting exclusive rights to acquire the company and its technology.
  • We represented a specialty pharmaceutical client in its collaboration with a Chinese pharmaceutical company to develop and manufacture pharmaceutical products in China.
  • Our lawyers represented a Singapore-based public company in its joint venture with a privately held U.S. company to develop and market hardware and software products for postal, courier, and logistics markets.
  • We have negotiated joint development agreements with US, Swiss, Canadian, and Chinese pharmaceutical companies relating to both new compounds and generic versions of listed drugs on behalf of biotech and specialty pharmaceutical companies.
  • We represented a U.S. manufacturer in a joint venture with a Chinese partner for the construction of a manufacturing facility in Shanghai.
  • We represented a leading Canadian provider of diagnostic imaging technology in negotiating a series of arrangements to distribute its technology in conjunction with the products of the world’s top medical imaging equipment manufacturers.
  • We represented a U.S.-based pharmaceutical company and its India-based subsidiary in numerous licensing and joint venture transactions with major educational and government organizations in India and represented them in its sale to a British entity. Currently, we represent a principal of the acquired entities in a spin out of these entities, which involves among other issues, special purpose financing arranged through an Indian private equity fund and coordinating U.S. and Indian tax and securities laws.
  • Our lawyers represented a venture capital fund in its collaboration with a publicly traded Dutch company and a US executive in developing a web-based gaming site in the United Kingdom.
RESOURCES

Happenings, headlines and insights.
See what’s new at Davis Malm.

View Our Business Resources

Alerts

August 8, 2019

Massachusetts Cannabis Control Commission Proposes Revisions to Cannabis Regulations

Read More

Publications

August 7, 2019

Ex-client accuses Bowditch & Dewey of $20M gaffe

Read More

Publications

July 31, 2019

Landmark Win for Growers Who Wouldn’t Take “No” For An Answer

Read More

Publications

July 29, 2019

An Estate Tax Trap for Foreign Real Estate Investors

Read More

Speaking Engagements

June 21, 2019

Foreign Investments in U.S. Real Estate – Tax Law, Entity Selection and Transaction Structures

Read More

Publications

March 13, 2019

Marijuana entrepreneurs see favorable precedent in Worcester court ruling

Read More

Speaking Engagements

February 14, 2019

Navigating the US Regulatory, Compliance & Tax Landscape

Read More

Publications

January 29, 2019

Pot Still a No Go For NFL Players, Despite Legalization

Read More

Speaking Engagements

January 18, 2019

Tax Considerations for Emerging Cannabis Businesses

Read More
Contact Us

Need Business Counsel?

Get in touch
Scroll to Top